Morgan Stanley · VRTX Holdings Trend
Vertex Pharmaceuticals · SEC 13F
Morgan Stanley Holdings of VRTX by Quarter
Quarter Shares Value
| Quarter | Shares | Value | QoQ Change |
|---|---|---|---|
| 2024Q1 | 3.5M | $1.3B | — |
| 2024Q2 | 10.5M | $4.1B | +205.9% |
| 2024Q3 | 10.7M | $4.3B | +5.2% |
| 2024Q4 | 7.5M | $2.7B | -36.3% |
| 2025Q1 | 15.0M | $6.0B | +116.7% |
| 2025Q2 | 7.1M | $1.5B | -74.8% |
| 2025Q3 | 4.1M | $1.2B | -17.4% |
| 2025Q4 | 6.5M | $1.4B | +15.6% |
| 2026Q1 | 20.8M | $4.2B | +189.4% |
← Back to VRTX holders ← Back to VRTX profile
Data source: SEC EDGAR Form 13F